scholarly journals The influence of orally administered short chain fatty acids on intestinal histopathological changes and intensity of Trichinella spiralis infection in mice

2010 ◽  
Vol 55 (No. 6) ◽  
pp. 264-274 ◽  
Author(s):  
D. Mista ◽  
J. Piekarska ◽  
M. Houszka ◽  
W. Zawadzki ◽  
M. Gorczykowski

The influence of short chain fatty acids (SCFA) on histopathological changes in the small intestine and the intensity of invasion of T. spiralis in mice were investigated in this study. The animals were infected with doses of 500 and 250 T. spiralis larvae per mouse. A SCFA solution containing acetic, propionic and butyric acid (30 : 15 : 20mM) was administered orally to the mice starting from the 5<sup>th</sup> day before infection to the 20<sup>th</sup> day after infection (day). Fragments of the jejunum collected during dissection on the 7th and 10th day were used to prepare specimens to assess the histopathological changes. In the infected animals, the intestinal trichinellae were counted on the 7<sup>th</sup> and 10<sup>th</sup> day, while on the 42<sup>nd</sup> day the muscle larvae number were determined. The strongest host reaction in the intestine was observed on the 7<sup>th</sup> day at a dose of T. spiralis 500 larvae, and on the 10<sup>th</sup> day at a dose of 250 larvae. Numerous inflammatory infiltrations, strong shortening of the intestinal villi, extension of the intestinal crypts, and the lowest ratio of the villi length to the intestinal crypts depth were observed. The ratio was 1.3 &plusmn; 0.3 on the 7<sup>th</sup> day at a dose of 500 larvae, and on the 10<sup>th</sup> day, at dose of 250 larvae the ratio reached 1.5 &plusmn; 0.5. Both values differed significantly from the control group: 3.3 &plusmn; 0.5 (P &lt; 0.01). Administration of SCFA to the animals infected with T. spiralis caused remission of local histopathological changes resulting from the presence of the parasite in the small intestine after the mentioned periods. This manifested as limited villi shortening and reduced deepening of intestinal crypts. At the higher infectious dose, in animals receiving the acid solution, on the 7<sup>th</sup> day the intestinal villi were considerably longer (356 &micro;m &plusmn; 35) than in the group infected with T. spiralis but not treated with the acids (279 &micro;m &plusmn; 57; P &lt; 0.01). At a lower dose of parasites, on the 10<sup>th</sup> day these values were 339 &micro;m &plusmn; 88 and 306 &micro;m &plusmn; 47 respectively and the observed differences were not statistically significant. The solution of SCFA also caused a decrease in the numbers of mature parasites in the intestine and the muscle larvae at a dose of 500 larvae/mouse. In animals receiving the SCFA, 24 050 &plusmn; 10 415 larvae were observed in muscles, while in the infected mice, which did not receive the acids, 32 875 &plusmn; 16 762 larvae were detected (P &lt; 0.05). An increase in the intensity of infection accelerated the rate of host reaction to the presence of T. spiralis in the intestines (self-cure). To summarize, the administered solution of short chain fatty acids alleviated the formation of histopathological changes in the intestine in response to the parasite's presence, and lowered the intensity of T. spiralis invasion after infection with a higher dose of larvae. &nbsp;

2019 ◽  
Vol 366 (13) ◽  
Author(s):  
Katarzyna Śliżewska ◽  
Agnieszka Chlebicz

ABSTRACT The aim of this study was to estimate the influence of synbiotics on intestinal microbiota and its metabolism in sows. Three different synbiotics were administered with feed to animals from three experimental groups. Two groups of sows were given commercially available probiotics (BioPlus 2B®, Cylactin® LBC) as forage additives for comparison. The control group of sows was given unmodified fodder. The study was conducted for 48 days (10 days before farrowing, and continued 38 days after) and faeces samples were collected four times. The scope of this work was to designate the dominant microbiota in sows’ faeces. Therefore, the total number of anaerobic bacteria, Bifidobacterium sp., Lactobacillus sp., Bacteroides sp., Clostridium sp., Enterococcus sp., Enterobacteriaceae, Escherichia coli and yeast was determined, using the plate method. Changes in the concentration of lactic acid, short-chain fatty acids (SCFAs) and branched-chain fatty acids (BCFAs) were also determined in correlation with the feed additives administered to the sows using high-performance liquid chromatography analysis (HPLC). Our results allowed us to conclude that synbiotics have a beneficial effect on intestinal microbiota of sows and its metabolism. We observed that the impact of the synbiotics on the microbiota was more significant than the one induced by probiotics.


Molecules ◽  
2021 ◽  
Vol 26 (9) ◽  
pp. 2464
Author(s):  
Zhan-Dong Yang ◽  
Yi-Shan Guo ◽  
Jun-Sheng Huang ◽  
Ya-Fei Gao ◽  
Fei Peng ◽  
...  

In vitro experiments have indicated prebiotic activity of isomaltulose, which stimulates the growth of probiotics and the production of short chain fatty acids (SCFAs). However, the absence of in vivo trials undermines these results. This study aims to investigate the effect of isomaltulose on composition and functionality of gut microbiota in rats. Twelve Sprague–Dawley rats were divided into two groups: the IsoMTL group was given free access to water containing 10% isomaltulose (w/w), and the control group was treated with normal water for five weeks. Moreover, 16S rRNA sequencing showed that ingestion of isomaltulose increased the abundances of beneficial microbiota, such as Faecalibacterium and Phascolarctobacterium, and decreased levels of pathogens, including Shuttleworthia. Bacterial functional prediction showed that isomaltulose affected gut microbial functionalities, including secondary bile acid biosynthesis. Targeted metabolomics demonstrated that isomaltulose supplementation enhanced cholic acid concentration, and reduced levels of lithocholic acid, deoxycholic acid, dehydrocholic acid, and hyodeoxycholic acid. Moreover, the concentrations of propionate and butyrate were elevated in the rats administered with isomaltulose. This work suggests that isomaltulose modulates gut microbiota and the production of SCFAs and secondary bile acids in rats, which provides a scientific basis on the use of isomaltulose as a prebiotic.


2021 ◽  
Vol 55 (2) ◽  
pp. 98-103
Author(s):  
M.V. Stoykevich ◽  
N.S. Fedorova ◽  
N.V. Nedzvetskaya ◽  
I.A. Klenina ◽  
O.M. Tatarchuk

Background. The pathogenesis of chronic inflammatory bowel disease (IBD) is still not fully clarified. It is known that disorders of the intestinal microbiota lead to an increased intestinal permeability, activation of mucous and adaptive immunity, impaired production and intestinal absorption of short-chain fatty acids (SCFA). The ratio of acetic, propionic, butyric acids is an important indicator of the integrity of the intestinal microbial community. Thus, the study of the composition of the intestinal microbiota and the concentrations of fecal SCFA is a very promi­sing approach to broadening the understanding of IBD pathoge­nesis. The purpose of our study was to determine the features of the production of fecal SCFA and the composition of colon microbiota in patients with IBD. Materials and methods. The study, which was carried out at the Department of Intestinal Diseases of the Institute of Gastroenterology of the National Academy of Medical Sciences of Ukraine, involved 74 patients with IBD with an average age of (43.2 ± 1.8) years, who according to nosology were divided into 2 groups: group I — those with ulcerative colitis (UC) (n = 66), group II — individuals with Crohn’s disease (CD) (n = 8). The diagnoses of CD and UC were established accor­ding to generally accepted diagnostic standards in gastroenterology. Determination of fecal SCFA was carried out by chromatographic method with the use of hardware-software complex for medical researches on the basis of the gas chromatographer Chromateс Crystal 5000. The intestinal microflora was evaluated using a microbiological study of the colon content. Results. Patients with IBD had significant changes in the spectrum of SCFA, which were similar in both UC and CD: a decrease in acetic acid in the UC group by 5.7 times, in the CD group by 10.5 times (p < 0.05), butyric acid in the UC group by 1.6 times, in the CD group by 1.5 times (p < 0.05), and an increase in propionic acid in the UC group by 4 times and in the CD group by 3.3 times (p < 0.05) compared with the control group. There was also a significant increase in the anaerobic index in patients with IBD. Microbiological study of feces showed a significant decrease in Lactobacillus, which was observed in all patients with IBD, as well as a decrease in Bifidobacterium in 19.7 % of those with UC and in 37.5 % with CD. There was a decrease of other representatives of the normal microflora: Enterococci (in 15.2 % in the UC group and 25 % in the CD group) and Escherichia coli (in 15.2 % in the UC group and 12.5 % in the CD group). Excessive growth of opportunistic flora was also detected: hemolytic Escherichia coli was increased in 19.7 % of patients with UC and in 12.5 % of those with CD; Proteus was detected in 12.1 % of people with UC and in 37.5 % with CD. The excessive growth of Candida was found in 43.9 % of patients in the UC group and in 87.5 % of indivi­duals with CD. Conclusions. Quantitative and qualitative deviations of the intestinal microbiota, such as a decrease in the number of major symbionts and an increase in the number of opportunistic pathogens, were observed in all examined patients with IBD. The obtained results showed that changes in SCFA concentrations in both nosologies of IBD differed significantly from those in the control group, which in combination with primary genetic defects of the barrier function of the epithelium and its regenerative abi­lity can lead to deterioration in the course and prognosis of IBD. Evalua­tion of the ratio of SCFA fractions with the calculation of the anaerobic index may be useful for the diagnosis of intestinal dysbiosis in patients with IBD.


2021 ◽  
Vol 99 (10) ◽  
Author(s):  
Xiaorong Yu ◽  
Chunsheng Fu ◽  
Zhenchuan Cui ◽  
Guangyong Chen ◽  
Yinglei Xu ◽  
...  

Abstract Constipation in gestating and lactating sows is common and the inclusion of dietary fiber may help to alleviate this problem. We investigated the effects of inulin (INU) and isomalto-oligosaccharide (IMO), two sources of soluble dietary fiber, on gastrointestinal motility-related hormones, short-chain fatty acids (SCFA), fecal microflora, and reproductive performance in pregnant sows. On day 64 of gestation, 30 sows were randomly divided into three groups and fed as follows: a basal diet, a basal diet with 0.5% INU, and a basal diet with 0.5% IMO. We found that INU and IMO significantly modulated the levels of gastrointestinal motility-related hormones, as evidenced by an increase in substance P (P &lt; 0.05), and a decrease in the vasoactive intestinal peptide concentrations (P &lt; 0.05), indicating the capacity of INU and IMO to alleviate constipation. Furthermore, IMO enhanced the concentrations of acetic, propionic, isobutyric, butyric, isovaleric, and valeric acids in the feces (P &lt; 0.05). High-throughput sequencing showed that IMO and INU increased the fecal microflora α- and β-diversity (P &lt; 0.05). Methanobrevibacter was more abundant (P &lt; 0.05), whereas the richness of Turicibacter was lower in the INU and IMO groups than in the control group (P &lt; 0.05). In addition, IMO significantly increased litter size (P &lt; 0.05). Overall, our findings indicate that INU and IMO can relieve constipation, optimize intestinal flora, and promote reproductive performance in pregnant sows.


2020 ◽  
Vol 21 (2) ◽  
pp. 445 ◽  
Author(s):  
Sini Kang ◽  
Hyun Ju You ◽  
Yeong-Geun Lee ◽  
Yunju Jeong ◽  
Tony V. Johnston ◽  
...  

Short-chain fatty acids (SCFAs), especially butyrate, produced in mammalian intestinal tracts via fermentation of dietary fiber, are known biofunctional compounds in humans. However, the variability of fermentable fiber consumed on a daily basis and the diversity of gut microbiota within individuals often limits the production of short-chain fatty acids in the human gut. In this study, we attempted to enhance the butyrate levels in human fecal samples by utilizing butyl-fructooligosaccharides (B-FOS) as a novel prebiotic substance. Two major types of B-FOS (GF3-1B and GF3-2B), composed of short-chain fructooligosaccharides (FOS) bound to one or two butyric groups by ester bonds, were synthesized. Qualitative analysis of these B-FOS using Fourier transform infrared (FT-IR) spectroscopy, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS), nuclear magnetic resonance (NMR) and low-resolution fast-atom bombardment mass spectra (LR-FAB-MS), showed that the chemical structure of GF3-1B and GF3-2B were [O-(1-buty-β-D-fru-(2→1)-O-β-D-fru-(2→1)-O-β-D-fru-O-α-D-glu] and [O-(1-buty)-β-D-fru-(2→1)-O-β-D-fru-(2→1)-O-(4-buty)-β-D-fru-O-α-D-glu], respectively. The ratio of these two compounds was approximately 5:3. To verify their biofunctionality as prebiotic oligosaccharides, proliferation and survival patterns of human fecal microbiota were examined in vitro via 16S rRNA metagenomics analysis compared to a positive FOS control and a negative control without a carbon source. B-FOS treatment showed different enrichment patterns on the fecal microbiota community during fermentation, and especially stimulated the growth of major butyrate producing bacterial consortia and modulated specific butyrate producing pathways with significantly enhanced butyrate levels. Furthermore, the relative abundance of Fusobacterium and ammonia production with related metabolic genes were greatly reduced with B-FOS and FOS treatment compared to the control group. These findings indicate that B-FOS differentially promotes butyrate production through the enhancement of butyrate-producing bacteria and their metabolic genes, and can be applied as a novel prebiotic compound in vivo.


1998 ◽  
Vol 128 (6) ◽  
pp. 947-953 ◽  
Author(s):  
Hetty M. G. van Beers-Schreurs ◽  
Marius J. A. Nabuurs ◽  
Liebe Vellenga, ◽  
Hilda J. Kalsbeek-van der Valk ◽  
Theo Wensing ◽  
...  

2006 ◽  
Vol 21 (suppl 4) ◽  
pp. 2-7 ◽  
Author(s):  
José de Souza Neves ◽  
José Eduardo de Aguilar-Nascimento ◽  
Maria Helena Gaiva Gomes-da-Silva ◽  
Rosecélia Nunes Cavalcanti ◽  
Alberto Salomão Bicudo ◽  
...  

PURPOSE: To investigate the effect of oral glutamine alone or combined with short chain fatty acids (SCFA) in the intestinal adaptation of rats submitted to an massive enterectomy. METHODS: After receiving 70% small bowel resection, 30 Wistar rats were randomized to received either standard rat chow (control group, n=10) or the same diet supplemented with 3,05% of glutamine alone (glutamine group, n=10) or combined with a solution containing SCFA (glutamine+SCFA group, n=10). Animals were killed on the 14th postoperative day. Mucosal weight, crypt depth, villus height, wall width, and the mucosal content of DNA, were assessed in basal conditions (resected gut specimen) and compared to the small bowel specimen collected on the postoperative day 14, at both jejunum and ileum sites. RESULTS: All groups presented similar pattern in weight evolution. In all groups, both the morphological findings and the DNA content were significantly higher at the end of the experiment than in basal conditions, at both the jejunum and ileum. Except for the jejunum wall width that was higher in control group (808±95 µ) than in the other two groups (glutamine = 649±88 µ and glutamine+SCFA = 656±92; p<0.01), there was no difference among them in all variables at both intestinal sites after 14 days. CONCLUSION: All groups presented adaptation of the intestinal mucosa in the remnant gut. Glutamine combined or not with short chain fatty acids fails to influence the adaptive response of the small bowel.


2019 ◽  
Vol 366 (Supplement_1) ◽  
pp. i133-i146
Author(s):  
Katarzyna Śliżewska ◽  
Agnieszka Chlebicz

ABSTRACT The aim of this study was to estimate the influence of synbiotics on intestinal microbiota and its metabolism in sows. Three different synbiotics were administered with feed to animals from three experimental groups. Two groups of sows were given commercially available probiotics (BioPlus 2B®, Cylactin® LBC) as forage additives for comparison. The control group of sows was given unmodified fodder. The study was conducted for 48 days (10 days before farrowing, and continued 38 days after) and faeces samples were collected four times. The scope of this work was to designate the dominant microbiota in sows’ faeces. Therefore, the total number of anaerobic bacteria, Bifidobacterium sp., Lactobacillus sp., Bacteroides sp., Clostridium sp., Enterococcus sp., Enterobacteriaceae, Escherichia coli and yeast was determined, using the plate method. Changes in the concentration of lactic acid, short-chain fatty acids (SCFAs) and branched-chain fatty acids (BCFAs) were also determined in correlation with the feed additives administered to the sows using high-performance liquid chromatography analysis (HPLC). Our results allowed us to conclude that synbiotics have a beneficial effect on intestinal microbiota of sows and its metabolism. We observed that the impact of the synbiotics on the microbiota was more significant than the one induced by probiotics.


Sign in / Sign up

Export Citation Format

Share Document